144 related articles for article (PubMed ID: 17005000)
1. Coping with the isotretinoin registry.
Baldwin HE
Dermatol Ther; 2006; 19(4):241-50. PubMed ID: 17005000
[TBL] [Abstract][Full Text] [Related]
2. A pox on your practice. iPLEDGE program scars dermatologists.
Ortolon K
Tex Med; 2006 May; 102(5):29-31. PubMed ID: 17115578
[No Abstract] [Full Text] [Related]
3. Accutane risk management program strengthened.
FDA Consum; 2002; 36(1):8. PubMed ID: 11881607
[No Abstract] [Full Text] [Related]
4. Accutane-exposed pregnancies--California, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Jan; 49(2):28-31. PubMed ID: 10680601
[TBL] [Abstract][Full Text] [Related]
5. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
Brinker A; Kornegay C; Nourjah P
Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
[TBL] [Abstract][Full Text] [Related]
6. Continued occurrence of Accutane-exposed pregnancies.
Honein MA; Paulozzi LJ; Erickson JD
Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
[TBL] [Abstract][Full Text] [Related]
7. Terminations of pregnancy associated with isotretinoin use in New Zealand.
Moodie P; Jaine R; Arnold J; Metcalfe S; Bignall M; Arroll B
N Z Med J; 2011 Jul; 124(1339):59-66. PubMed ID: 21952331
[TBL] [Abstract][Full Text] [Related]
8. Young women taking isotretinoin still conceive. Role of physicians in preventing disaster.
Atanackovic G; Koren G
Can Fam Physician; 1999 Feb; 45():289-92. PubMed ID: 10065298
[TBL] [Abstract][Full Text] [Related]
9. Isotretinoin prescribing: finding a balance between benefit and risk.
Stern RS
Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):611-3. PubMed ID: 16134100
[No Abstract] [Full Text] [Related]
10. A risk management program aimed at preventing fetal exposure to isotretinoin: retrospective cohort study.
Cheetham TC; Wagner RA; Chiu G; Day JM; Yoshinaga MA; Wong L
J Am Acad Dermatol; 2006 Sep; 55(3):442-8. PubMed ID: 16908350
[TBL] [Abstract][Full Text] [Related]
11. Relapse of acne following isotretinoin treatment: a retrospective study of 405 patients.
Liu A; Yang DJ; Gerhardstein PC; Hsu S
J Drugs Dermatol; 2008 Oct; 7(10):963-6. PubMed ID: 19112761
[TBL] [Abstract][Full Text] [Related]
12. The cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin).
Doshi A
Seton Hall Law Rev; 2007; 37(2):625-60. PubMed ID: 17294569
[No Abstract] [Full Text] [Related]
13. What is the best approach to reducing birth defects associated with isotretinoin?
Abroms L; Maibach E; Lyon-Daniel K; Feldman SR
PLoS Med; 2006 Nov; 3(11):e483. PubMed ID: 17121451
[TBL] [Abstract][Full Text] [Related]
14. Accutane registry compulsory in US, but not Canada.
Andresen M
CMAJ; 2006 Jun; 174(12):1701. PubMed ID: 16754892
[No Abstract] [Full Text] [Related]
15. Safe use of acne drug.
FDA Consum; 2005; 39(6):4. PubMed ID: 16669109
[No Abstract] [Full Text] [Related]
16. [Teratogenicity of isotretinoin].
Orfanos CE
Hautarzt; 1984 Oct; 35(10):503-5. PubMed ID: 6238920
[No Abstract] [Full Text] [Related]
17. [Guidelines for the good use of isotretinoin in private practice: a prospective observational study of 1263 acne patients].
Jeanmougin M; Beaulieu P; Doutre MS; Jaramillo C
Ann Dermatol Venereol; 2009 Jan; 136(1):54-6. PubMed ID: 19171232
[No Abstract] [Full Text] [Related]
18. Possible isotretinoin-induced keloids in a patient with Behçet's disease.
Dogan G
Clin Exp Dermatol; 2006 Jul; 31(4):535-7. PubMed ID: 16716157
[TBL] [Abstract][Full Text] [Related]
19. A comparative review of the isotretinoin pregnancy risk management programs across four continents.
Kovitwanichkanont T; Driscoll T
Int J Dermatol; 2018 Sep; 57(9):1035-1046. PubMed ID: 29508918
[TBL] [Abstract][Full Text] [Related]
20. Changes in isotretinoin prescribing before and after implementation of the System to Manage Accutane Related Teratogenicity (SMART) risk management program.
Mendelsohn AB; Governale L; Trontell A; Seligman P
Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):615-8. PubMed ID: 15892175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
